WO1991012530A1 - Radiative transfer fluorescence assay - Google Patents

Radiative transfer fluorescence assay Download PDF

Info

Publication number
WO1991012530A1
WO1991012530A1 PCT/GB1991/000165 GB9100165W WO9112530A1 WO 1991012530 A1 WO1991012530 A1 WO 1991012530A1 GB 9100165 W GB9100165 W GB 9100165W WO 9112530 A1 WO9112530 A1 WO 9112530A1
Authority
WO
WIPO (PCT)
Prior art keywords
labelled
analyte
binding partner
binding
fluorescent material
Prior art date
Application number
PCT/GB1991/000165
Other languages
French (fr)
Inventor
William Arthur Bains
John Andrew Golby
Original Assignee
Pa Consulting Services Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pa Consulting Services Limited filed Critical Pa Consulting Services Limited
Priority to EP91906527A priority Critical patent/EP0594606A1/en
Priority to JP91504002A priority patent/JPH05506094A/en
Publication of WO1991012530A1 publication Critical patent/WO1991012530A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex

Definitions

  • This invention relates to fluorescence assays, using fluorescent materials as labels.
  • the invention is particularly applicable to immunoassays, based on the affinity of antibodies and antigens, but is also applicable to other types of assay using other pairs of reactants that bind specifically and selectively to each other.
  • a sample containing an unknown quantity of an antigen of interest is contacted with the corresponding antibody (monoclonal or polyclonal) immobilised on a solid support, and with a supply of fluorescently labelled antibody to the antigen. Any antigen in the sample will bind to the immobilised antibody and to the labelled antibody, resulting in formation of a fluorescently labelled immobilised "sandwich". After washing to remove any unbound reagents, if necessary, an indication can be obtained of the presence or amount of the antigen by monitoring light emitted by the fluorescent label material in response to
  • one molecule of fluorescent label material is typically associated with each molecule of antibody, so that only a small amount of light is emitted for each molecule of bound antigen, which limits significantly the sensitivity of the technique.
  • a sample containing an unknown quantity of an antigen of interest is introduced into a solution of the corresponding antibody labelled with monodisperse latex spheres in the size range 0.1- 1.0um. Any antigen in the sample will bind to the labelled antibody and multiple binding causes the latex spheres to bind together.
  • Any binding can be detected by monitoring the optical properties of the solution, specifically the angular distribution of light scattered from an incident beam, this test is homogenous, ie does not require a separate washing stage, but is relatively insensitive because it requires many thousands or millions of binding events.to cause a detectable change in the scattered light.
  • the present invention aims to provide a homogeneous assay, i.e. one that does not require a washing stage prior to detection.
  • the invention also aims, in preferred embodiments at least, to provide an assay capable of greater sensitivity than conventional agglutination and fluorescence assays.
  • SUBSTITUTESHEET fluorescence assay for determining the presence in a sample of an analyte or binding partner to which the analyte binds specifically and selectively, comprising contacting the sample with a quantity of binding partner or analyte labelled with a first fluorescent material A and with a quantity of binding partner or analyte labelled with a second fluorescent material B, a unit of substance labelled with A and a unit of substance labelled with B both being capable of binding simultaneously to a single particle of analyte or binding partner or being capable of binding to each other, A and B being selected such that B is capable of being stimulated by radiative transfer fluorescence by light emitted from A when suitably stimulated, and B is not significantly stimulated by light which acts to stimulate A; if necessary adding to the sample a quantity of the analyte or binding partner; and monitorin _*g light emitted from B in response to suitable stimulation of A.
  • a fluorescence assay for determining the presence in a sample of an analyte or binding partner to which the analyte binds specifically and selectively, comprising contacting the sample with a quantity of binding partner labelled with a first fluorescent material A and with a quantity of binding partner labelled with a second fluorescent material B, a unit of binding partner labelled with A and a unit of binding partner labelled with B both being capable of binding simultaneously to a single particle of analyte, A and B being selected such that B is capable of being stimulated by radiative transfer fluorescence by light emitted from A when suitably stimulated, and B is not significantly stimulated by light which acts to stimulate A; and monitoring light emitted
  • the phenomenon of radiative transfer fluorescence involves photons passing from a first fluorescent material (A) to a second fluorescent material (B) and an inverse square law applies so that a significant amount of light will only be emitted from the second fluorescent material when sufficiently .close to the first fluorescent material.
  • A first fluorescent material
  • B second fluorescent material
  • this is only likely to occur when a unit of substance labelled with A and a unit of substance labelled with B are bound in close proximity, e.g. by both being bound to a single particle of analyte, so that the emission of light from B is indicative- of the presence of analyte.
  • an indication can be obtained of the quantity of analyte present in the sample.
  • the method may be used qualitatively or quantitively, in the latter case by comparing results with those for known standards.
  • SUBSTITUTE SHEET events will result in a unit of bidding partner labelled with A and a unit of binding partner labelled with B being bound to a single molecule of analyte, forming an AB pair, rather than AA or BB pairs. Multiple binding events, if present, will increase sensitivity if each A can excite more than one B.
  • the method of the invention typically finds application in an immunoassay, e.g. using labelled antigens to detect an antibody of interest in a sample, with two labelled antigens binding to the antigen binding sites of each molecule of antibody of interest.
  • an antigen of interest may be detected by using two types of differently labelled antibodies, each antibody type binding to a different determinant of the antigen.
  • Such an arrangement would theoretically result in production of 100% AB pairs on binding. It is also possible to use bispecific antibodies to increase the proportion of AB pairs on binding. It is envisaged the method could also be used in a competition assay, for instance with labelled antigen being used to detect antigen in the sample by competing for binding to added antibody.
  • the A and B materials may be used to label antibody and antigen respectively.
  • the A and B units would all bind together.
  • any target antigen would compete with the labelled antigen for binding sites and thus reduce the signal level.
  • the method of the invention can also be used for detection of enzymes or DNA species, and for detection of other materials as will be apparent to those skilled in the art.
  • the A arid B labels may be associated with two different DNA probes which will bind
  • SUBSTITUTE SHEET o specific sites on the target DNA, such that the A and B labels will be sufficiently close for efficient radiative fluorescence transfer i.e. label B should be within a few particle diameters of label A.
  • the technique can also be used to detect molecules such as cholesterol by coating the labels with enzymes which bind to the target substrate. In principle the reverse is also possible, i.e. detection of enzymes by labels coated with substrate.
  • each unit of binding partner is preferably labelled with more than one molecule of fluorescent material A or B. This is conveniently achieved by encapsulating a large number of molecules of A or B in a particle of suitable carrier material and attaching binding partner to the particle.
  • the particle is conveniently in the form of a microsphere or microparticle having a diameter in the range 1 to 100 microns.
  • each unit of binding partner may comprise a large number of fluorophores, possibly in the range of 10 ⁇ to 1012, providing a substantial amplification effect.
  • the fluorescent material is an organic dye solution
  • large numbers of molecules may be encapsulated in cross- linked gelatin or other protein shells by forming emulsions in water-immiscible solvents, microcapsules of protein and carbohydrate such as gum arabic (as is used in carbonless copying paper), by in-situ polymerisation of a polymer such as polyacrylamide, polystyrene or nylon by precipitation of polymer around droplets of dye or by other methods. See “Microcapsule Processing and Technology", A. Konder and J.W. VQ ⁇ Valkenburg, Marcel Dekker Inc., 1979 for further details.
  • the fluorescent material comprises a solid state flu ⁇ rophore such as neodymium ions (Nd 3+) or other laser media
  • neodymium ions Nd 3+
  • these are conveniently doped into a glass or similar host, which may be produced in the form of microspheres or ground into small particles.
  • Proteins, including antibodies, may be bound to particles by a wide range of known techniques.
  • One technique is non-covalent adsorption, as described in "Antibodies: a laboratory manual” by E. Harlow and D.Lane, Cold Spring Harbour Lab., 1988, chapter 14.
  • a range of covalent links may also be used e.g. to an adsorbed protein via glutaraldehyde, p,p'difluoro-m.m'-dinitrophenylsulphone (FNPS) or similar bifunctional reagent: see "Handbook of experimental immunology:1, immunochemistry” ed D.M. Weir, L.A. Herzenberg, Blackwell 1986, p 35.26.
  • Proteins may also be bound directly to "activated" plastics following treatment with cyanogen bromide, tocyl chloride etc (see Harlow and Lane pp 528-9) or directly to beads with active surface groups such as tocyl, chloride, etc. (as produced by, for example. Bangs Lab Inc. Car el, Indiana, U.S.A).
  • DNA probes may be bound to such beads by labelling the DNA with bi ⁇ tin and binding this to avidin, itself bound to beads as described above (see e.g. T. Hultman, S. Stahl, E. Homes, M. ⁇ hler, "Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support", Nucleic Acids Research 1*989 in press), or covalently by cross-linking using UV light (see E.W.K. Landjian, BioTechnology 5 ⁇ , 165-167,(1987), "Optimised hybridisation of DNA blotted and fixed to nitrocellulose and nylon membranes"), or by introducing a reactive functional group into the DNA (see e.g. J.N. Kremsky, J.L.
  • DNA may also be linked to a support (which has been previously derivatized with a linker DNA) using enzymatic or chemical means (Pocket et al ibid. )
  • proteins including antibodies
  • proteins may be bound to glass essentially as to plastics, as described above.
  • proteins may be adsorbed to clean glass surfaces or cross-linked to covalently activated glass.
  • DNA may be adsorbed non- covalently or cross-linked to activated glass, again essentially as described above; see e.g. S.S. Ghosh and F.G. Musso "Covalent attachment of oligonucleotide to solid supports" Nucleic Acids Research 13, 5353-5372, (1987).
  • Suitable pairs of fluorescent materials A and B can be selected such that A is stimulated by light of a first wavelength (or within a first range of wavelengths) L . and emits light of a second, longer wavelength (or range of wavelengths) L 2 which in turn stimulates B to emit light of a third, longer wavelength (or range of wavelengths) A->2 > It is also necessary for L- j and L 2 to be distinct from each other, with no overlap, so that undesired stimulation of B on exposure to light of wavelength L_ j does not occur.
  • A is the dye Styryl 9, e.g. as available commercially from Lambda Physik and other manufacturers. Graphs showing the absorption and fluorescence characteristics of Styryl 9 dye are given in "The Performance of Dyes and Dye Mixtures of Rhodamine 6G/Rhodamine 560 and of Styryl 8/Styryl 9 for Single Mode CW Ring Laser Operation", by J.J.L. Mulders, and L.W.G-. Steenhuysen in Optics Communications, volume 54 number 5, pages 295-298, July 1985. Brielfy, L_
  • Nd:glass e.g. having a composition of 66 wt % Si0 2 , 5wt %
  • the excitation wavelength L.. for Styryl 9 has excitation peaks L 2 at 740nm and 810nm (i.e. 20nm wide absorption peaks centred on those wavelengths), a fluorescence wavelength L 3 of 1060nm and a quantum efficiency of about 0.4.
  • it has a long fluorescence lifetime, between 0.1 and 1 ms, allowing time gating against dye A fluorescence, as will be described below. This enables particle sizes to be optimised for minimum background due to direct excitation, as will also be described below.
  • the transfer efficiency of fluorescence transfer is very low, and it is accordingly important to optimise conditions to enhance the overall gain as far as possible. In particular, it is important to reduce background signals as far as possible.
  • Time gating may be used to eliminate the possibility of background signals arising from the first two of these sources. This involves using a fluorescent material B with a longer fluorescence decay time than material A and detecting L., photons after the expiry of the fluorescence of A (ie after a few fluorescence lifetimes of A).
  • the preferred pair of materials mentioned above satisfy this requirement, as Styryl 9 has a fluorescent decay of about 10 - 15 ns, while that of Nd: glass is between 0.1 and 1 ms.
  • Material C preferably has low absorbance of light of the wavelength used to excite A, although this is not essential.
  • one suitable material C is the dye known as S101756 which is commercially available from ICI Colours and Fine Chemical. This dye is soluble in non-polar solvents and has a high molar extinction coefficient (about 120,000) peaking at 770nm.
  • a dye with similar characteristics, but which is water soluble, known as S116510, is also available, as are broadband infrared absorbing dyes S109186, and S109564 (see ICI Technical Data Sheets).
  • Another way of monitoring non-specific binding is to label an antigen (different from that labelled with A and B) with a third material. This antigen will be chosen to have the same degree of non-specific binding to A as B, and the label will be chosen either to absorb L ⁇ and fluoresce at a different wavelength to B, e.g. L., or alternatively to absorb L 2 and not fluoresce.
  • a second detector and filter could monitor the amount of light at
  • the detector monitors the amount of light at L 2 , which will decrease if non-specific binding occurs. It will be seen that in the second case, the label is required to have the same properties as material C which is used to increase the fluorescent gain, and it is thus possible to use microspheres containing dye C coated with an appropriate non-specific antigen.
  • the illuminating source is conveniently a flash lamp or a light emitting diode (LED). These have properties as follows:
  • an LED is less powerful, its higher directivity allows more efficient coupling to the sample, and it can be modulated at kHz frequencies to allow phase sensitive detection. It is also cheaper, and may not require a bandpass filter. For these reasons an LED is the currently favoured source.
  • the presently preferred light detector is a silicon photodiode, despite the reduced responsivity at 1060nm wavelength.
  • a standard device (BPX 65) has an NEP of
  • a large area photodiode (1cm ) has an NEP of about 1pW//H ⁇ " .
  • the assay of the invention is capable of high sensitivity, possibly being able to detect only a few thousand particles of target material under suitably optimised conditions, which can be carried out using relatively cheap, compact apparatus and which has a wide range of applicability, to detection of antibodies, enzymes, DNA etc.
  • FIG 1 illustrates schematically apparatus for performing the method of the invention
  • FIG. 1 illustrates the timing cycle of the apparatus of Figure 1.
  • the apparatus illustrated in Figure 1 comprises a cuvette 10 with capacity 500 nun for receiving reagents, which is located in an ellipsoidal reflector 12.
  • An LED 14 and associated lens 16 are located on the axis of the reflector, outside the reflector, for supplying illuminating light onto the cuvette via a suitable aperture 18 in the reflector.
  • LED 14 has the following characteristics.
  • the apparatus further comprises a silicon photodiode light detector 20, positioned on the reflector axis. Because of relatively poor off axis imaging performance, it is appropriate to use a detector 20 with a relatively large area of about 1cm , having an NEP (noise equivalent power) of about 1pW//HZ " . Alternatively the detector could be positioned directly by the cuvette. As a further possibility dichroic filters may be used so that the detector selectively reflects and transmits the pump radiation and fluorescent radiation from the cuvette, with some cost penalty.
  • a suitable quantity of a sample containing an unknown quantity of a substance of interest e.g. a particular antibody
  • a suitable quantity of a sample containing an unknown quantity of a substance of interest e.g. a particular antibody
  • qunatities of antigen corresponding to the antibody and separately labelled with two different fluorescent materials A and B are added to the cuvette.
  • the fluorescent materials A and B are both in the form of encapsulated microspheres, as described above, with the antigen bound to the surfaces thereof, as also described above.
  • material A is the dye Styryl 9, as described above, which is encapsulated by one of the techniques described above, e.g. by polymerisation of a polymer such as polyacrylamide around droplets of the dye, to form microsphere with a radius of
  • N 100 urn.
  • the number density of the spheres, N is in the range 10mm —3 to 1000mm—3.
  • Material B is Nd: glass, as
  • SUBSTITUTESHEET described above, formed or ground into microspheres with a radius of 10um. With both types of sphere, the antigen is bound to the surface by one of the techniques described above, e.g. by non-covalent adsorption.
  • a quantity of the fluorescence-absorbing dye S101756 (material C) is also added to the cuvette, either in the form of a ' solution or encapsulated as microspheres with a radius of lum. - f
  • the cuvette is illuminated by the LED 14 and emitted light monitored by detector 20 in accordance with the timing cycle illustrated in Figure 2. As illustrated, LED 14 is operated for short, discrete intervals 22, during which time detector 20 is switched off.
  • the illumination of the contents of cuvette 10 causes A to fluoresce and consequential fluorescence of B by radiative transfer fluorescence for adjacent pairs of A and B labelled microspheres both bound to the same molecule of antibody of interest.
  • the presence of fluorescence from B the timing of which is illustrated in Figure 2, thus indicates the presence of the antibody of interest.
  • detector 20 is operated in discrete intervals 24 while LED 14 is switched off, with a small time interval 26 being left between switching off LED 14 and switching on detector 20 to allow the fluorescence of A to decay fully (in a few microseconds).
  • a small time interval 28 is left between switching off detector 20 and switching on LED 14 at the start of the next cycle to
  • SUBSTITUTESHEET avoid any risk of unwanted detection of illuminating light.
  • the apparatus may thus include a second cuvette and associated components as shown in Figure 1, for receiving the labelled reagents but no test sample. Light emitted from both cuvettes is measured periodically, and the amount of target analyte determined by comparing the results.

Abstract

A fluorescence assay for determining the presence in a sample of an analyte or binding partner to which the analyte binds specifically and selectively, comprises contacting the sample with a quantity of binding partner or analyte labelled with a first fluorescent material A and with a quantity of binding partner or analyte labelled with a second fluorescent material B, a unit of substance labelled with A and a unit of substance labelled with B both being capable of binding simultaneously to a single particle of analyte of binding partner or being capable of binding to each other, A and B being selected such that B is capable of being stimulated by radiative transfer fluorescence by light emitted from A when suitably stimulated, and B is not significantly stimulated by light which acts to stimulate A; if necessary adding to the sample a quantity of the analyte or binding partner; and monitoring light emitted from B in response to suitable stimulation of A. A preferred combination is the dye Styryl 9(A) and Nd3+(B) in the form of Nd:glass particles.

Description

Title: RADIATIVE T-RA SFER FLDC_SESCENCE ASSAY
DESCRIPTION
"Field of the invention
This invention relates to fluorescence assays, using fluorescent materials as labels. The invention is particularly applicable to immunoassays, based on the affinity of antibodies and antigens, but is also applicable to other types of assay using other pairs of reactants that bind specifically and selectively to each other.
Background to the invention
In a typical fluorescence sandwich immunoassay, a sample containing an unknown quantity of an antigen of interest is contacted with the corresponding antibody (monoclonal or polyclonal) immobilised on a solid support, and with a supply of fluorescently labelled antibody to the antigen. Any antigen in the sample will bind to the immobilised antibody and to the labelled antibody, resulting in formation of a fluorescently labelled immobilised "sandwich". After washing to remove any unbound reagents, if necessary, an indication can be obtained of the presence or amount of the antigen by monitoring light emitted by the fluorescent label material in response to
SUBSTITUTE SHEET suitable stimulation.
In conventional assays, one molecule of fluorescent label material is typically associated with each molecule of antibody, so that only a small amount of light is emitted for each molecule of bound antigen, which limits significantly the sensitivity of the technique.
In a typical agglutination assay, a sample containing an unknown quantity of an antigen of interest is introduced into a solution of the corresponding antibody labelled with monodisperse latex spheres in the size range 0.1- 1.0um. Any antigen in the sample will bind to the labelled antibody and multiple binding causes the latex spheres to bind together.
Any binding can be detected by monitoring the optical properties of the solution, specifically the angular distribution of light scattered from an incident beam, this test is homogenous, ie does not require a separate washing stage, but is relatively insensitive because it requires many thousands or millions of binding events.to cause a detectable change in the scattered light.
The present invention aims to provide a homogeneous assay, i.e. one that does not require a washing stage prior to detection. The invention also aims, in preferred embodiments at least, to provide an assay capable of greater sensitivity than conventional agglutination and fluorescence assays.
Summary of the invention
According to the present invention there is provided a
SUBSTITUTESHEET fluorescence assay for determining the presence in a sample of an analyte or binding partner to which the analyte binds specifically and selectively, comprising contacting the sample with a quantity of binding partner or analyte labelled with a first fluorescent material A and with a quantity of binding partner or analyte labelled with a second fluorescent material B, a unit of substance labelled with A and a unit of substance labelled with B both being capable of binding simultaneously to a single particle of analyte or binding partner or being capable of binding to each other, A and B being selected such that B is capable of being stimulated by radiative transfer fluorescence by light emitted from A when suitably stimulated, and B is not significantly stimulated by light which acts to stimulate A; if necessary adding to the sample a quantity of the analyte or binding partner; and monitorin _*g light emitted from B in response to suitable stimulation of A.
In a preferred aspect of the present invention there is provided a fluorescence assay for determining the presence in a sample of an analyte or binding partner to which the analyte binds specifically and selectively, comprising contacting the sample with a quantity of binding partner labelled with a first fluorescent material A and with a quantity of binding partner labelled with a second fluorescent material B, a unit of binding partner labelled with A and a unit of binding partner labelled with B both being capable of binding simultaneously to a single particle of analyte, A and B being selected such that B is capable of being stimulated by radiative transfer fluorescence by light emitted from A when suitably stimulated, and B is not significantly stimulated by light which acts to stimulate A; and monitoring light emitted
SUBSTITUTESHEET from B in response to suitable stimulation of A.
The phenomenon of radiative transfer fluorescence involves photons passing from a first fluorescent material (A) to a second fluorescent material (B) and an inverse square law applies so that a significant amount of light will only be emitted from the second fluorescent material when sufficiently .close to the first fluorescent material. When carrying out the assay of the invention, this is only likely to occur when a unit of substance labelled with A and a unit of substance labelled with B are bound in close proximity, e.g. by both being bound to a single particle of analyte, so that the emission of light from B is indicative- of the presence of analyte. By monitoring the intensity of light emitted, an indication can be obtained of the quantity of analyte present in the sample.
Because unbound B will not generally emit the light there is no need to remove unbound reagents e.g. by washing. The method thus provides a homogeneous, single step assay.
The method may be used qualitatively or quantitively, in the latter case by comparing results with those for known standards.
In certain embodiments it may be appropriate for reference purposes to obtain results from two similar systems, one with sample and one without sample.
It is preferred to use equal numbers of units of A labelled binding partner and B labelled binding partner. In this case, in the absence of any dual binding scheme, as discussed below, it is probable that half the binding
SUBSTITUTE SHEET events will result in a unit of bidding partner labelled with A and a unit of binding partner labelled with B being bound to a single molecule of analyte, forming an AB pair, rather than AA or BB pairs. Multiple binding events, if present, will increase sensitivity if each A can excite more than one B.
The method of the invention typically finds application in an immunoassay, e.g. using labelled antigens to detect an antibody of interest in a sample, with two labelled antigens binding to the antigen binding sites of each molecule of antibody of interest. Alternatively an antigen of interest may be detected by using two types of differently labelled antibodies, each antibody type binding to a different determinant of the antigen. Such an arrangement would theoretically result in production of 100% AB pairs on binding. It is also possible to use bispecific antibodies to increase the proportion of AB pairs on binding. It is envisaged the method could also be used in a competition assay, for instance with labelled antigen being used to detect antigen in the sample by competing for binding to added antibody. As a further possibility, the A and B materials may be used to label antibody and antigen respectively. In the absence of any target antigen (or antibody) the A and B units would all bind together. However, any target antigen would compete with the labelled antigen for binding sites and thus reduce the signal level.
The method of the invention can also be used for detection of enzymes or DNA species, and for detection of other materials as will be apparent to those skilled in the art. For example, for a DNA test the A arid B labels may be associated with two different DNA probes which will bind
SUBSTITUTE SHEET o specific sites on the target DNA, such that the A and B labels will be sufficiently close for efficient radiative fluorescence transfer i.e. label B should be within a few particle diameters of label A. The technique can also be used to detect molecules such as cholesterol by coating the labels with enzymes which bind to the target substrate. In principle the reverse is also possible, i.e. detection of enzymes by labels coated with substrate.
In order to increase the amount of light emitted and so improve sensitivity of the method, each unit of binding partner is preferably labelled with more than one molecule of fluorescent material A or B. This is conveniently achieved by encapsulating a large number of molecules of A or B in a particle of suitable carrier material and attaching binding partner to the particle. The particle is conveniently in the form of a microsphere or microparticle having a diameter in the range 1 to 100 microns. In this way each unit of binding partner may comprise a large number of fluorophores, possibly in the range of 10β to 1012, providing a substantial amplification effect.
Where the fluorescent material is an organic dye solution, large numbers of molecules may be encapsulated in cross- linked gelatin or other protein shells by forming emulsions in water-immiscible solvents, microcapsules of protein and carbohydrate such as gum arabic (as is used in carbonless copying paper), by in-situ polymerisation of a polymer such as polyacrylamide, polystyrene or nylon by precipitation of polymer around droplets of dye or by other methods. See "Microcapsule Processing and Technology", A. Konder and J.W. VQΠ Valkenburg, Marcel Dekker Inc., 1979 for further details.
SUBSTITUTESHEET Where the fluorescent material comprises a solid state fluόrophore such as neodymium ions (Nd 3+) or other laser media, these are conveniently doped into a glass or similar host, which may be produced in the form of microspheres or ground into small particles.
Proteins, including antibodies, may be bound to particles by a wide range of known techniques. One technique is non-covalent adsorption, as described in "Antibodies: a laboratory manual" by E. Harlow and D.Lane, Cold Spring Harbour Lab., 1988, chapter 14. A range of covalent links may also be used e.g. to an adsorbed protein via glutaraldehyde, p,p'difluoro-m.m'-dinitrophenylsulphone (FNPS) or similar bifunctional reagent: see "Handbook of experimental immunology:1, immunochemistry" ed D.M. Weir, L.A. Herzenberg, Blackwell 1986, p 35.26. Proteins may also be bound directly to "activated" plastics following treatment with cyanogen bromide, tocyl chloride etc (see Harlow and Lane pp 528-9) or directly to beads with active surface groups such as tocyl, chloride, etc. (as produced by, for example. Bangs Lab Inc. Car el, Indiana, U.S.A).
DNA probes may be bound to such beads by labelling the DNA with biόtin and binding this to avidin, itself bound to beads as described above (see e.g. T. Hultman, S. Stahl, E. Homes, M. ϋhler, "Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support", Nucleic Acids Research 1*989 in press), or covalently by cross-linking using UV light (see E.W.K. Landjian, BioTechnology 5^, 165-167,(1987), "Optimised hybridisation of DNA blotted and fixed to nitrocellulose and nylon membranes"), or by introducing a reactive functional group into the DNA (see e.g. J.N. Kremsky, J.L.
SUBSTITUTESHEET Wooters, J.P. Dougherty, R.E. Meyers, M. Collins, E.L. Brown "Immobilisation of DNA via oligonucleotides containing an aldehyde or carboxylic acid group at the 5 ' terminus", Nucleic Acids Research JJ^ 2891-2909 (1987); B. Connolly, "The syntheis of oligonucleotides containing a primary amino group at the 5' terminus" Nucleic Acids Research _15_, 3131-3139 (1987); S. Pocket, B.Arcangioli, T. Huynh-Dinh, "Solid supported ligation primer", Nucleic Acids Research, 16, 1619). DNA may also be linked to a support (which has been previously derivatized with a linker DNA) using enzymatic or chemical means (Pocket et al ibid. )
When considering glass microparticles, proteins, including antibodies, may be bound to glass essentially as to plastics, as described above. Specifically, proteins may be adsorbed to clean glass surfaces or cross-linked to covalently activated glass. DNA may be adsorbed non- covalently or cross-linked to activated glass, again essentially as described above; see e.g. S.S. Ghosh and F.G. Musso "Covalent attachment of oligonucleotide to solid supports" Nucleic Acids Research 13, 5353-5372, (1987).
Suitable pairs of fluorescent materials A and B can be selected such that A is stimulated by light of a first wavelength (or within a first range of wavelengths) L . and emits light of a second, longer wavelength (or range of wavelengths) L2 which in turn stimulates B to emit light of a third, longer wavelength (or range of wavelengths) A->2 > It is also necessary for L-j and L2 to be distinct from each other, with no overlap, so that undesired stimulation of B on exposure to light of wavelength L_j does not occur.
SUBSTITUTESHEET One preferred pair of materials which satisfies these requirements is as follows:
A is the dye Styryl 9, e.g. as available commercially from Lambda Physik and other manufacturers. Graphs showing the absorption and fluorescence characteristics of Styryl 9 dye are given in "The Performance of Dyes and Dye Mixtures of Rhodamine 6G/Rhodamine 560 and of Styryl 8/Styryl 9 for Single Mode CW Ring Laser Operation", by J.J.L. Mulders, and L.W.G-. Steenhuysen in Optics Communications, volume 54 number 5, pages 295-298, July 1985. Brielfy, L_| is about 650mm and L2 is 700-800 mm.
B is the solid state fluorophore Nd 3+ in the form of
Nd:glass, e.g. having a composition of 66 wt % Si02, 5wt %
Nd203, 16 wt % Na20, 5 wt % BaO, 2 wt % 1203 and 1 wt %
SbjO,. Such material has an absorption free window around
650nm (the excitation wavelength L.. for Styryl 9), has excitation peaks L2 at 740nm and 810nm (i.e. 20nm wide absorption peaks centred on those wavelengths), a fluorescence wavelength L3 of 1060nm and a quantum efficiency of about 0.4. In addition it has a long fluorescence lifetime, between 0.1 and 1 ms, allowing time gating against dye A fluorescence, as will be described below. This enables particle sizes to be optimised for minimum background due to direct excitation, as will also be described below.
The transfer efficiency of fluorescence transfer is very low, and it is accordingly important to optimise conditions to enhance the overall gain as far as possible. In particular, it is important to reduce background signals as far as possible.
SUBSTITUTE SHEET Background signals can arise from three main sources:
1. detection of L^ photons,
2. detection of L2 photons,
3. direct excitation of B by L_. photons.
Time gating may be used to eliminate the possibility of background signals arising from the first two of these sources. This involves using a fluorescent material B with a longer fluorescence decay time than material A and detecting L., photons after the expiry of the fluorescence of A (ie after a few fluorescence lifetimes of A). The preferred pair of materials mentioned above satisfy this requirement, as Styryl 9 has a fluorescent decay of about 10 - 15 ns, while that of Nd: glass is between 0.1 and 1 ms.
Having eliminated sources 1 and 2, conditions such as relative sphere size, number density etc., can then be adjusted to minimise background signals from source 3, without having to worry about the conflicting effects of such adjustment on sources 1 and 2. Calculations based on a simple theoretical model suggest good results can be obtained with the radius of particles labelled with A (r,) being 10 times the radius of particles labelled with B
(r ). Suitable particle sizes may be
Figure imgf000012_0001
The increase in fluorescence on binding and hence sensitivity can be increased by adding a material C which absorbs the A fluorescence but does not fluoresce itself. This has the effect of reducing the background signal due to unbound B in solution fluorescing without affecting the
SUBSTITUTESHEET signal in the bound state
Material C preferably has low absorbance of light of the wavelength used to excite A, although this is not essential. For the preferred materials A and B discussed above, one suitable material C is the dye known as S101756 which is commercially available from ICI Colours and Fine Chemical. This dye is soluble in non-polar solvents and has a high molar extinction coefficient (about 120,000) peaking at 770nm. A dye with similar characteristics, but which is water soluble, known as S116510, is also available, as are broadband infrared absorbing dyes S109186, and S109564 (see ICI Technical Data Sheets). There are various alternative dyes, including several laser dyes such as I 1 0, IR132 which could be used provided the fluorescence of these could be quenched while maintaining their absorption properties.
Problems can arise due to non-specific binding, i.e. binding between A and B labelled substances in the absence of the target analyte, due to extraneous biological material in the sample. It is not possible to reduce this effect other than by careful selection of the labelled analytes or binding partners. However, the magnitude of the effect should be monitored, in order not to overestimate the amount of analyte present. One way of monitoring non-specific binding is to label an antigen (different from that labelled with A and B) with a third material. This antigen will be chosen to have the same degree of non-specific binding to A as B, and the label will be chosen either to absorb L~ and fluoresce at a different wavelength to B, e.g. L., or alternatively to absorb L2 and not fluoresce. In the first case, a second detector and filter could monitor the amount of light at
SUBSTITUTESHEET Ϊ14, and hence determine the amount of non-specific binding. In the second case, the detector monitors the amount of light at L2, which will decrease if non-specific binding occurs. It will be seen that in the second case, the label is required to have the same properties as material C which is used to increase the fluorescent gain, and it is thus possible to use microspheres containing dye C coated with an appropriate non-specific antigen.*
The illuminating source is conveniently a flash lamp or a light emitting diode (LED). These have properties as follows:
Flashlamp LED
Mean power 0.1 - 1 W 10mW
(in 20nm band)
Wavelength Whitelight 660 +_ 15nm
Pulse rate up to 100Hz up to 1MHz
Directivity 4 pi steradians about 1 steradian
Although an LED is less powerful, its higher directivity allows more efficient coupling to the sample, and it can be modulated at kHz frequencies to allow phase sensitive detection. It is also cheaper, and may not require a bandpass filter. For these reasons an LED is the currently favoured source.
The presently preferred light detector is a silicon photodiode, despite the reduced responsivity at 1060nm wavelength. A standard device (BPX 65) has an NEP of
SUBSTITUTE SHEET 1 A - - about 3 x 10 W//HZ. A large area photodiode (1cm ) has an NEP of about 1pW//HΪ".
It is thought that the assay of the invention is capable of high sensitivity, possibly being able to detect only a few thousand particles of target material under suitably optimised conditions, which can be carried out using relatively cheap, compact apparatus and which has a wide range of applicability, to detection of antibodies, enzymes, DNA etc.
A preferred embodiment of the invention will now be described, by way of example, with reference to the accompanying drawings, in which:
Figure 1 illustrates schematically apparatus for performing the method of the invention; and
Figure 2 illustrates the timing cycle of the apparatus of Figure 1.
Detailed description of the drawings
The apparatus illustrated in Figure 1 comprises a cuvette 10 with capacity 500 nun for receiving reagents, which is located in an ellipsoidal reflector 12.* An LED 14 and associated lens 16 are located on the axis of the reflector, outside the reflector, for supplying illuminating light onto the cuvette via a suitable aperture 18 in the reflector. LED 14 has the following characteristics.
Mean power 1OmW
Wavelength 660- +_ 15 nm
SUBSTITUTE SHEET Pulse rate up to 1MHz
Directivity about 1 steradian
The apparatus further comprises a silicon photodiode light detector 20, positioned on the reflector axis. Because of relatively poor off axis imaging performance, it is appropriate to use a detector 20 with a relatively large area of about 1cm , having an NEP (noise equivalent power) of about 1pW//HZ". Alternatively the detector could be positioned directly by the cuvette. As a further possibility dichroic filters may be used so that the detector selectively reflects and transmits the pump radiation and fluorescent radiation from the cuvette, with some cost penalty.
In use a suitable quantity of a sample containing an unknown quantity of a substance of interest, e.g. a particular antibody, is located in the cuvette. In order to determine the presence or quantity of the antibody in the sample, qunatities of antigen corresponding to the antibody and separately labelled with two different fluorescent materials A and B, are added to the cuvette. The fluorescent materials A and B are both in the form of encapsulated microspheres, as described above, with the antigen bound to the surfaces thereof, as also described above.
In the presently preferred arrangement, material A is the dye Styryl 9, as described above, which is encapsulated by one of the techniques described above, e.g. by polymerisation of a polymer such as polyacrylamide around droplets of the dye, to form microsphere with a radius of
100 urn. The number density of the spheres, N, is in the range 10mm —3 to 1000mm—3. Material B is Nd: glass, as
SUBSTITUTESHEET described above, formed or ground into microspheres with a radius of 10um. With both types of sphere, the antigen is bound to the surface by one of the techniques described above, e.g. by non-covalent adsorption.
Approximately equal numbers of A labelled spheres and B labelled spheres are used.
A quantity of the fluorescence-absorbing dye S101756 (material C) is also added to the cuvette, either in the form of a 'solution or encapsulated as microspheres with a radius of lum. -f
The cuvette is illuminated by the LED 14 and emitted light monitored by detector 20 in accordance with the timing cycle illustrated in Figure 2. As illustrated, LED 14 is operated for short, discrete intervals 22, during which time detector 20 is switched off. The illumination of the contents of cuvette 10 causes A to fluoresce and consequential fluorescence of B by radiative transfer fluorescence for adjacent pairs of A and B labelled microspheres both bound to the same molecule of antibody of interest. The presence of fluorescence from B, the timing of which is illustrated in Figure 2, thus indicates the presence of the antibody of interest.
In order to take advantage of the time gating effect discussed above, detector 20 is operated in discrete intervals 24 while LED 14 is switched off, with a small time interval 26 being left between switching off LED 14 and switching on detector 20 to allow the fluorescence of A to decay fully (in a few microseconds). A small time interval 28 is left between switching off detector 20 and switching on LED 14 at the start of the next cycle to
SUBSTITUTESHEET avoid any risk of unwanted detection of illuminating light.
It may be desirable to reference the assay against a "blank" cuvette, i.e. one containing the labelled reagents but not the test sample. The apparatus may thus include a second cuvette and associated components as shown in Figure 1, for receiving the labelled reagents but no test sample. Light emitted from both cuvettes is measured periodically, and the amount of target analyte determined by comparing the results.
Some form of mixing/agitation will also be necessary in order for binding to occur in convenient times.cales e.g. a few minutes.
It is thought it may be possible to detect the presence of as few a thousands of target particles of interest.
SUBSTITUTE SHEET

Claims

1. A"fluorescence assay for determining the presence in a sample of an analyte or binding partner to which the analyte binds specifically and selectively, comprising contacting the sample with a quantity of binding partner or analyte labelled with a first fluorescent material A and with a quantity of binding partner or analyte labelled with a second fluorescent material B, a unit of substance labelled with A and a unit of substance labelled with B both being capable of binding simultaneously to a single particle of analyte or binding partner or being capable of binding to each other, A and B being selected such that B is capable of being stimulated by radiative transfer fluorescence by light emitted from A when suitably stimulated, and B is not significantly stimulated by light which acts to stimulate A; if necessary adding to the sample a quantity of the analyte or binding partner; and monitoring light emitted from B in response to suitable stimulation of A.
2. A fluorescence assay for determining the presence in a sample of an analyte or binding partner to which the analyte binds specifically and selectively, comprising contacting the sample with a quantity of binding partner labelled with a first fluorescent material A and with a quantity of binding partner labelled with a second fluorescent material B, a unit of binding partner labelled with A and a unit of binding partner labelled with B both being capable of binding simultaneously to a single particle of analyte, A and B being selected such that B is capable of being stimulated by radiative transfer fluorescence by light emitted from A when suitably
SUBSTITUTESHEET stimulated, and B is not significantly stimulated by light which acts to stimulate A; and monitoring light emitted from B in response to suitable stimulation of A.
3. An assay according to claim 1 or 2, wherein each unit of binding partner is labelled with more than one molecule of fluorescent material A or B.
4. An assay according to claim 3, wherein a large number of molecules of A or B are encapsulated in a particle of suitable carrier material and analyte or binding partner is attached to the particle.
5. An assay according to claim 4, wherein the particle is in the form of a microsphere or microparticle having a diameter in the range 1 to 100 microns.
6. An assay according to any one of the preceding claims, wherein fluorescent material A is the dye styryl 9, and fluorescent material B is the solid state fluorophore Nd 3+ in the form of Nd:glass.
7. An assay according to any one of the preceding claims, wherein fluorescent material B has a longer fluorescence decay time than material A, and wherein light emitted from material B is detected after the expiry of the fluorescence of A.
8. An assay according to any one of the preceding claims, wherein the radius of particles labelled with A (r ) is 10 times the radius of particles labelled with B (r„).
9. An assay according to any one of the preceding claims, further comprising adding to the sample a material C
SUBSTITUTE SHEET which absorbs light emitted from A but does not fluoresce* itself.
10. An assay according to claim 9, wherein fluorescent material A is the dye Styryl 9, fluorescent material B is the solid state fluorophore Nd 3+ in the form of Ndrglass, and material C is selected from the dyes known as S101756,
S116510, S109186, S109564, IR140, and IR132.
11. An assay according to any one of the preceding claims, wherein non-specific binding is monitored by labelling a further antigen with a third material, the further antigen having the same degree of non-specific binding to A as B, and the label absorbing light emitted from A and either fluorescing at a different wavelength to B, or not fluorescing.
SUBSTITUTE SHEET
PCT/GB1991/000165 1990-02-16 1991-02-05 Radiative transfer fluorescence assay WO1991012530A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP91906527A EP0594606A1 (en) 1990-02-16 1991-02-05 Radiative transfer fluorescence assay
JP91504002A JPH05506094A (en) 1990-02-16 1991-02-05 Radiative transfer fluorescence assay

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909003593A GB9003593D0 (en) 1990-02-16 1990-02-16 Improvements in or relating to fluorescence assays
GB9003593.2 1990-02-16

Publications (1)

Publication Number Publication Date
WO1991012530A1 true WO1991012530A1 (en) 1991-08-22

Family

ID=10671155

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1991/000165 WO1991012530A1 (en) 1990-02-16 1991-02-05 Radiative transfer fluorescence assay

Country Status (5)

Country Link
EP (1) EP0594606A1 (en)
JP (1) JPH05506094A (en)
AU (1) AU7237691A (en)
GB (1) GB9003593D0 (en)
WO (1) WO1991012530A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0536593A1 (en) * 1991-10-01 1993-04-14 Canon Kabushiki Kaisha Method and apparatus for specimen measurement, and reagent therefor
EP0577092A2 (en) * 1992-07-02 1994-01-05 Becton, Dickinson and Company Immunoassays using microparticles containing different detectable substances
WO1999012033A2 (en) * 1997-08-28 1999-03-11 Otogene Aktiengesellschaft Method and kit for identifying interactions between proteins or peptides
WO2001013119A1 (en) * 1999-08-17 2001-02-22 Luminex Corporation Encapsulation of fluorescent particles
US8173800B2 (en) 2006-08-15 2012-05-08 The Regents Of The University Of California Luminescent macrocyclic lanthanide complexes
US9273059B2 (en) 2009-08-24 2016-03-01 Lumiphore, Inc. Macrocyclic HOPO chelators
US9556122B2 (en) 2006-07-10 2017-01-31 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126450A2 (en) * 1983-05-19 1984-11-28 Ioannis Dr. Tripatzis Particle and method for the detection of antigens and/or antibodies using this particle
EP0150905A2 (en) * 1984-01-05 1985-08-07 Ortho Diagnostic Systems Inc. Anti-idiotype assay using fluorescent energy transfer
WO1987007385A1 (en) * 1986-05-27 1987-12-03 Ethigen Corporation Fluorescence immunoassay involving energy transfer between two fluorophores
WO1987007955A1 (en) * 1986-06-17 1987-12-30 Baxter Travenol Laboratories, Inc. Homogeneous fluoroassay methods employing fluorescent background rejection and water-soluble rare earth metal chelate fluorophores
US4719182A (en) * 1985-03-18 1988-01-12 Eastman Kodak Company Fluorescent labels and labeled species and their use in analytical elements and determinations
US4735907A (en) * 1985-03-18 1988-04-05 Eastman Kodak Company Stabilized fluorescent rare earth labels and labeled physiologically reactive species
US4780423A (en) * 1986-12-09 1988-10-25 Ciba Corning Diagnostics Corp. Heterogeneous fluorescence assays using controlled pore glass particles
EP0296136A1 (en) * 1987-06-16 1988-12-21 Wallac Oy Biospecific multianalyte assay method with labelled microparticles
US4822733A (en) * 1985-05-28 1989-04-18 Amoco Corporation Lifetime-resolved assay procedures
US4868103A (en) * 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126450A2 (en) * 1983-05-19 1984-11-28 Ioannis Dr. Tripatzis Particle and method for the detection of antigens and/or antibodies using this particle
EP0150905A2 (en) * 1984-01-05 1985-08-07 Ortho Diagnostic Systems Inc. Anti-idiotype assay using fluorescent energy transfer
US4719182A (en) * 1985-03-18 1988-01-12 Eastman Kodak Company Fluorescent labels and labeled species and their use in analytical elements and determinations
US4735907A (en) * 1985-03-18 1988-04-05 Eastman Kodak Company Stabilized fluorescent rare earth labels and labeled physiologically reactive species
US4822733A (en) * 1985-05-28 1989-04-18 Amoco Corporation Lifetime-resolved assay procedures
US4868103A (en) * 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
WO1987007385A1 (en) * 1986-05-27 1987-12-03 Ethigen Corporation Fluorescence immunoassay involving energy transfer between two fluorophores
WO1987007955A1 (en) * 1986-06-17 1987-12-30 Baxter Travenol Laboratories, Inc. Homogeneous fluoroassay methods employing fluorescent background rejection and water-soluble rare earth metal chelate fluorophores
US4780423A (en) * 1986-12-09 1988-10-25 Ciba Corning Diagnostics Corp. Heterogeneous fluorescence assays using controlled pore glass particles
EP0296136A1 (en) * 1987-06-16 1988-12-21 Wallac Oy Biospecific multianalyte assay method with labelled microparticles

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0536593A1 (en) * 1991-10-01 1993-04-14 Canon Kabushiki Kaisha Method and apparatus for specimen measurement, and reagent therefor
US5601983A (en) * 1991-10-01 1997-02-11 Canon Kabushiki Kaisha Method for specimen measurement
EP0577092A2 (en) * 1992-07-02 1994-01-05 Becton, Dickinson and Company Immunoassays using microparticles containing different detectable substances
EP0577092A3 (en) * 1992-07-02 1994-09-07 Becton Dickinson Co Immunoassays using microparticles containing different detectable substances
WO1999012033A2 (en) * 1997-08-28 1999-03-11 Otogene Aktiengesellschaft Method and kit for identifying interactions between proteins or peptides
WO1999012033A3 (en) * 1997-08-28 1999-06-10 Otogene Biotechnologische Fors Method and kit for identifying interactions between proteins or peptides
WO2001013119A1 (en) * 1999-08-17 2001-02-22 Luminex Corporation Encapsulation of fluorescent particles
US6905766B2 (en) 1999-08-17 2005-06-14 Luminex Corporation Encapsulation of discrete quanta of fluorescent particles
US9556122B2 (en) 2006-07-10 2017-01-31 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
US8173800B2 (en) 2006-08-15 2012-05-08 The Regents Of The University Of California Luminescent macrocyclic lanthanide complexes
US8729258B2 (en) 2006-08-15 2014-05-20 The Regents Of The University Of California Luminescent macrocyclic lanthanide complexes
US9273059B2 (en) 2009-08-24 2016-03-01 Lumiphore, Inc. Macrocyclic HOPO chelators
US10352938B2 (en) 2009-08-24 2019-07-16 Lumiphore, Inc. Macrocyclic HOPO chelators
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles

Also Published As

Publication number Publication date
EP0594606A1 (en) 1994-05-04
JPH05506094A (en) 1993-09-02
GB9003593D0 (en) 1990-04-11
AU7237691A (en) 1991-09-03

Similar Documents

Publication Publication Date Title
US4153675A (en) Immunofluorometric method and apparatus for measuring minute quantities of antigens, antibodies and other substances
US4368047A (en) Process for conducting fluorescence immunoassays without added labels and employing attenuated internal reflection
JP3608665B2 (en) Optical waveguide method for detecting specific binding events by light scattering.
US5624850A (en) Immunoassays in capillaries
US7332344B2 (en) Luminescence assays
US4882288A (en) Assay technique and equipment
JP3444630B2 (en) Surface enhanced Raman spectrum immunoassay
EP0606460B1 (en) Assay system
EP0167335B1 (en) Method of detecting binding reaction between ligand and anti-ligand
US6165798A (en) Optical quantification of analytes in membranes
CA1253798A (en) Homogeneous fluorescence immunoassay using at light absorbing material
US20140170674A1 (en) Membraine-Based Assay Devices Utilizing Time-Resolved Up-Converting Luminescence
AU748633B2 (en) Capillary assay method
WO1991012530A1 (en) Radiative transfer fluorescence assay
JP2005509158A (en) Microchip type enzyme-linked immunosorbent assay (ELISA) concentration measuring apparatus and concentration measuring method
US20220365092A1 (en) A method for detecting an analyte
Starodub et al. Construction and biomedical application of immunosensors based on fiber optics and enhanced chemiluminescence
Walt et al. Fluorescent optical sensors
US20240060891A1 (en) A method for detecting an analyte
WO2023180747A1 (en) A method for detecting an analyte
Bains A rapid particle-based immunoassay system using fluorescence transfer detection William Bains and John Golby
JP2023059089A (en) Method for detecting or quantifying detection object in sample, and reagent for detecting or quantifying detection object in sample

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CA CH DE DK ES FI GB HU JP KP KR LK LU MC MG MW NL NO PL RO SD SE SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1991906527

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWP Wipo information: published in national office

Ref document number: 1991906527

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1991906527

Country of ref document: EP